Drug Trial Radar · NCT07294898
A Study to Investigate the Effect of a Low-fat Meal and Evening Dosing on KAI-7535 in Participants Living With Obesity or Overweight
Last checked: Nov 19, 2026Latest source record: Jan 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
18
Actual
Start
Dec 15, 2025
Primary completion
Jan 26, 2026
Study completion Jan 26, 2026
Sponsor
- Lead sponsor
- KaileraIndustry
- Sponsor type
- Industry
- First posted
- Dec 19, 2025
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Crossover
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 55 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The primary objective of this study is to evaluate the effect of a meal and evening dosing on the pharmacokinetics (PK) of KAI 7535 in healthy participants living with obesity or overweight.
Conditions
- Obesity
- Overweight
Interventions
KAI-7535Drug
Oral tablets.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time to Maximum Observed Concentration (Tmax) of KAI-7535Time frame: Pre-dose and up to 60 hours post-dose
- Maximum Observed Concentration (Cmax) of KAI-7535Time frame: Pre-dose and up to 60 hours post-dose
- Area Under the Concentration-time Curve From 0 to Time of Last Quantifiable Concentration (AUC0-t) of KAI-7535Time frame: Pre-dose and up to 60 hours post-dose
- Area Under the Concentration-time Curve From 0 to Infinity (AUC0-inf) of KAI-7535Time frame: Pre-dose and up to 60 hours post-dose
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Anaheim Clinical Trials
Anaheim, California
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.